Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy (HCM) is a cardiac disorder characterized by the abnormal thickening of the heart muscle, primarily affecting the left ventricle. This thickening can disrupt the heart's ability to pump blood efficiently, leading to various complications. HCM often has a genetic basis, with a familial predisposition, making individuals with a family history of the condition more susceptible. While some individuals with HCM may remain asymptomatic, others may experience chest pain, shortness of breath, or persistent fatigue. In severe cases, HCM can result in irregular heart rhythms, significantly increasing the risk of sudden cardiac arrest. Diagnosis of HCM typically involves a comprehensive assessment, incorporating medical history, physical examinations, and advanced diagnostic tests such as echocardiograms. Early detection is crucial for effective management and intervention. The management of HCM focuses on alleviating symptoms and preventing complications. Treatment options may encompass medications, lifestyle modifications, and, in extreme cases, surgical interventions. Medications may include beta-blockers or calcium channel blockers to regulate heart contractions. Lifestyle modifications often involve regular exercise tailored to individual capabilities, a heart-healthy diet, and the avoidance of certain activities that may exacerbate symptoms.